Andrew L. Finn
2013
In 2013, Andrew L. Finn earned a total compensation of $1.1M as Executive VP of Product Development at BioDelivery Sciences International, a 130% increase compared to previous year.
Compensation breakdown
| Bonus | $124,680 |
|---|---|
| Salary | $313,514 |
| Stock Awards | $672,961 |
| Other | $28,185 |
| Total | $1,139,340 |
Finn received $673K in stock awards, accounting for 59% of the total pay in 2013.
Finn also received $124.7K in bonus, $313.5K in salary and $28.2K in other compensation.
Rankings
In 2013, Andrew L. Finn's compensation ranked 6,043rd out of 12,286 executives tracked by ExecPay. In other words, Finn earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,043 out of 12,286 | 51st |
Division Manufacturing | 2,101 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 618 out of 1,462 | 58th |
Industry group Drugs | 444 out of 1,156 | 62nd |
Industry Pharmaceutical Preparations | 356 out of 890 | 60th |
Source: SEC filing on May 12, 2016.
Finn's colleagues
We found five more compensation records of executives who worked with Andrew L. Finn at BioDelivery Sciences International in 2013.
2013
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
2013
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
2013
Andrew FinnPharmD
BioDelivery Sciences International
Executive VP of Product Development
2013
Ernest De Paolantonio
BioDelivery Sciences International
Chief Financial Officer
2013
Ernest De PaolantonioCPA
BioDelivery Sciences International